Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)

NCT06001268 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-04-01

No results posted yet for this study

Summary

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are undergoing surgery.

Conditions

Interventions

BEHAVIORAL

Fitbit Data Collection

Participants will log food intake while sharing their data with a dietician in real time for 12 weeks

BEHAVIORAL

Nutrition Counseling

Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth or in person.

BEHAVIORAL

Survey

Participants will take a survey at baseline and weeks 4,8,\& 12. (FACT-G) Questionnaire includes questions about participant's physical, social, emotional and functional well being over the past 7 days. This questionnaire uses a 5 point Likert-type scale, 0=not at all, 4=very much. A higher total score indicates better quality of life.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Kea Turner, PhD · Moffitt Cancer Center

  • Pamela J Hodul, MD · Moffitt Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-14
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06001268 on ClinicalTrials.gov